Catalog2 refs
Vesilute
BioregulatorsHealing & RecoveryRussian bioregulatory peptideAnti-AgingResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
Overview
A Khavinson-style short peptide bioregulator aimed at the urinary bladder and lower urinary tract. Also known as ED Dipeptide, Glu-Asp, L-Glutamyl-L-Aspartic Acid. The claimed mechanism involves a very small peptide that can enter the cell nucleus, interact with chromatin and gene promoter regions, and adjust the expression of genes involved in bladder wall and smooth-muscle function. No peer-reviewed studies have been published specifically on Vesilute; claims are extrapolated from the broader Khavinson bioregulator family.
Primary Uses
Bladder and urinary function studies
Lower-urinary-tract support
Pelvic-floor and sphincter research
Urologic aging models
Supports bladder and urinary tract function
May improve prostate health in men
Regulates smooth muscle function
Enhances pelvic tissue blood flow
Supports cellular regeneration
Part of comprehensive Khavinson bioregulator protocols
Alleviate symptoms associated with benign prostatic hyperplasia (BPH)
Address age-related urogenital changes
vascular and reproductive system research
vascular and reproductive system support
Urogenital support
Bladder health
Prostate support (in combination with Prostamax)
Lower urinary tract function
Protocol Reference
Dose
10-20 mg daily
Frequency
1-2x daily, before meals
Half-life
Not Well Characterized
Route
Oral capsules
Evidence
Preclinical / Moderate Research (disputed)
Research Models
Human
Also in Bioregulators